- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/30 - Nitrogen atoms non-acylated
Patent holdings for IPC class C07D 295/30
Total number of patents in this class: 36
10-year publication summary
4
|
5
|
3
|
2
|
0
|
1
|
0
|
1
|
3
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Axolabs GmbH | 15 |
4 |
The Trustees of Columbia University in the City of New York | 3529 |
3 |
Abbvie Inc. | 1789 |
3 |
Sutter Bay Hospitals | 15 |
3 |
Centre National de La Recherche Scientifique | 10158 |
2 |
St. Mary's University | 10 |
2 |
Universite de Montpellier | 962 |
2 |
Janssen Pharmaceutica N.V. | 3606 |
1 |
Apogee Biotechnology Corporation | 16 |
1 |
Arizona Board of Regents on behalf of Arizona State University | 2484 |
1 |
Cambrex Karlskoga AB | 17 |
1 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 676 |
1 |
Innovascreen Inc. | 4 |
1 |
Lantheus Medical Imaging, Inc. | 172 |
1 |
Murdoch University | 71 |
1 |
Pharmos Corporation | 4 |
1 |
Reuter Chemische Apparatebau KG | 15 |
1 |
Suven Life Sciences Limited | 129 |
1 |
Synta Pharmaceuticals Corp. | 188 |
1 |
The United States Government AS represented by The Department of Veterans Affairs | 1110 |
1 |
Other owners | 4 |